In vivo requirements for activation of tumor-specific CD4+T cells

被引：0
|
作者：
Corthay, A [1 ]
Bogen, B [1 ]
机构：
[1] Univ Oslo, Inst Immunol, Oslo, Norway
来源：
INTERNATIONAL JOURNAL OF CANCER | 2002年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：156 / 156
页数：1
相关论文
共 50 条
  • [1] Naive tumor-specific CD4+T cells differentiated in vivo eradicate established melanoma
    Antony , Paul
    Xie, Ying
    Akpinarli, Akgul
    Maris, Charles
    Hipkiss, Edward
    Lane, Malcolm
    Kwon, Eun-Kyung
    Muranski, Pawel
    Restifo, Nicholas
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [2] Regulation and impact of tumor-specific CD4+T cells in cancer and immunotherapy
    Guo, Mengdi
    Liu, Melissa Yi Ran
    Brooks, David G.
    TRENDS IN IMMUNOLOGY, 2024, 45 (04) : 303 - 313
  • [3] Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells
    Church, Sarah E.
    Jensen, Shawn M.
    Antony, Paul A.
    Restifo, Nicholas P.
    Fox, Bernard A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2014, 44 (01) : 69 - 79
  • [4] Provision of tumor-specific CD4+T cells to enhance tumor immunity in a murine model of prostate cancer
    Shafer-Weaver, Kimberly Ann
    Malyguine, Anatoli
    Hurwitz, Arthur A.
    FASEB JOURNAL, 2008, 22
  • [5] In vivo tracking of tumor-specific T cells
    Yee, C
    Riddell, SR
    Greenberg, PD
    CURRENT OPINION IN IMMUNOLOGY, 2001, 13 (02) : 141 - 146
  • [6] Neoantigen-specific CD4+T cells induce protective, tumor-specific CD8+T cells in a mouse model of multiple myeloma.
    Bekri, Selma
    Rodney-Sandy, Reunet
    Bogen, Bjarne
    Levy, Daniel
    Cho, Hearn Jay
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E157 - E157
  • [7] High-dimensional profiling of tumor-infiltrating CD4+T cells in Human cancer: Are they all tumor-specific?
    Li, Shamin
    Simoni, Yannick
    Zhuang, Summer
    Heit, Antje
    Tan, Iain
    Tan, W. S. Daniel
    Newell, Evan
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [8] Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
    Xie, Ying
    Akpinarli, Akguel
    Maris, Charles
    Hipkiss, Edward L.
    Lane, Malcolm
    Kwon, Eun-Kyung M.
    Muranski, Pawel
    Restifo, Nicholas P.
    Antony, Paul Andrew
    JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 207 (03): : 651 - 667
  • [9] Tumor Immunology meets. Immunology: Modified cancer cells as professional APC for priming naive tumor-specific CD4+T cells
    Eddine, Farah Bou Nasser
    Ramia, Elise
    Tosi, Giovanna
    Forlani, Greta
    Accolla, Roberto S.
    ONCOIMMUNOLOGY, 2017, 6 (11):
  • [10] Tumor-specific CD4+T cells develop cytotoxic activity and eliminate virus-induced tumour cells in the absence of regulatory T cells
    Akhmetzyanova, I.
    Zelinskyy, G.
    Schimmer, S.
    Sparwasser, T.
    Dittmer, U.
    IMMUNOLOGY, 2012, 137 : 621 - 622
12345